2017-01-24
2026-01-24
2026-01-24
74
NCT03033927
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
OBSERVATIONAL
Predicting Effective Therapy in Pancreatic Cancer
The purpose of this phase II study is to develop a test to predict response of pancreatic cancer to different chemotherapy regimens.
N/A
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
| Study Registration Dates | Results Reporting Dates | Study Record Updates |
|---|---|---|
2017-01-25 | N/A | 2025-04-23 |
2017-01-25 | N/A | 2025-04-24 |
2017-01-27 | N/A | 2025-04 |
This section provides details of the study plan, including how the study is designed and what the study is measuring.
Primary Purpose:
N/A
Allocation:
N/A
Interventional Model:
N/A
Masking:
N/A
Arms and Interventions
| Participant Group/Arm | Intervention/Treatment |
|---|---|
| : Participants with Stage IV Pancreatic Cancer | DIAGNOSTIC_TEST: CTC isolocation and analysis
|
| Primary Outcome Measures | Measure Description | Time Frame |
|---|---|---|
| Progression Free Survival | in patients receiving frontline therapy predicted to be effective versus ineffective based on CTC PGx analysis | 36 months |
| Secondary Outcome Measures | Measure Description | Time Frame |
|---|
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person’s general health condition or prior treatments.
Ages Eligible for Study:
ALL
Sexes Eligible for Study:
18 Years
Accepts Healthy Volunteers:
This is where you will find people and organizations involved with this study.
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
NPCF was founded on May 29, 2009 and is a 501(c)(3) organization. All donations are tax deductible.
The information and services provided by the National Pancreatic Cancer Foundation are for informational purposes only. The information and services are not intended to be substitutes for professional medical advice, diagnosis or treatment. The National Pancreatic Cancer Foundation does not recommend nor endorse any specific physicians, products or treatments even though they may be mentioned on this site.
Copyright © 2024 – National Pancreatic Cancer Foundation | All Rights Reserved
